• Ceruletide in Pancreatic Function Research: Protocols & Inno

  2026-07-17

  Ceruletide (caerulein) delivers unmatched reproducibility for modeling pancreatic fibrosis and gastrointestinal physiology. Explore advanced workflows, troubleshooting insights, and the integration of cutting-edge MFGE8-axis science to elevate your digestive disorder research.

• Targeting Adipose Tissue Macrophages with ATS-9R/siCcl2 in G

  2026-07-17

  This study introduces a targeted non-viral gene delivery approach using ATS-9R/siCcl2 complexes to selectively silence Ccl2 in adipose tissue macrophages, reducing inflammation and insulin resistance in gestational diabetes mellitus (GDM). The findings provide mechanistic insights and translational promise for precision gene silencing in metabolic disease research.

• SIRT1-Regulated Ran Lactylation Drives Astrocyte Polarizatio

  2026-07-16

  This study reveals that lactate accumulation after spinal cord injury promotes astrocyte polarization through SIRT1-dependent lactylation of the Ran GTPase at lysine 123, enhancing STAT3 nuclear transport. These findings clarify a mechanistic link between metabolic signaling, epigenetic regulation, and neuroregenerative responses, offering new research directions for CNS injury models.

• Angiotensin 1/2 (5-7): Applied Workflows for RAS & Viral Res

  2026-07-16

  Angiotensin 1/2 (5-7) is a uniquely versatile peptide for probing blood pressure regulation and spike protein interactions in bench workflows. This guide details optimized protocols, troubleshooting advice, and cutting-edge applications that leverage APExBIO's analytically pure formulation.

• Cyclophosphamide: Strategic Insights for Translational Oncol

  2026-07-15

  This thought-leadership article explores Cyclophosphamide’s mechanistic foundations as an alkylating chemotherapeutic agent, its role in apoptosis induction, and its transformative impact on translational cancer research. Through evidence-backed protocols, competitive context, and forward-looking guidance, the article provides actionable strategies for maximizing reproducibility and data quality in experimental and preclinical workflows. It further distinguishes itself by connecting protocol optimization with emerging translational opportunities, referencing both foundational literature and recent workflow innovations.

• Marein Restores Chemosensitivity by Targeting ABCG2 in MDR C

  2026-07-15

  The referenced study reveals that marein, a natural polyphenol from Coreopsis tinctoria, competitively inhibits the ABCG2 transporter, reversing multidrug resistance (MDR) in cancer cells. By binding a conserved site on ABCG2, marein enhances intracellular drug retention, offering a novel approach to overcoming chemotherapy resistance in cancers expressing this transporter.

• Drug-Sensitized Yeast as a Platform for mTOR Inhibitor Disco

  2026-07-14

  The reference study introduces a drug-sensitized yeast system to dramatically enhance the sensitivity and reliability of screening for mTOR inhibitors. This approach enables rapid, cost-effective identification of compounds with TOR pathway inhibition potential, offering important implications for geroprotection and oncology drug discovery.

• Ionomycin Free Acid: Driving Precision in Calcium Ionophore

  2026-07-14

  Explore the scientific foundations and advanced applications of Ionomycin free acid as a selective calcium ionophore. This article uniquely bridges mechanistic insights with assay optimization, highlighting its role in intracellular calcium studies and new frontiers in focal adhesion kinase regulation.

• Phenothiazines Enhance Macrophage Antibacterial Activity via

  2026-07-13

  This study reveals that phenothiazines, including promethazine hydrochloride, significantly boost macrophage antibacterial capacity by inducing reactive oxygen species (ROS) and autophagy. These findings advance host-directed therapy strategies for combating intracellular bacterial infections and guide practical approaches for inflammation and immunometabolism research.

• SIRT1/2 Inhibitor IV (cambinol): Driving Translational CNS D

  2026-07-13

  Explore how SIRT1/2 Inhibitor IV (cambinol) empowers translational researchers to dissect SIRT-regulated lactylation and astrocyte polarization, bridging metabolic and epigenetic control in CNS injury and tumor models. This thought-leadership article provides mechanistic insights, actionable protocols, and strategic perspectives grounded in the latest evidence, highlighting both the transformative potential and practical deployment of cambinol.

• Promethazine HCl: Expanding Frontiers in Host-Directed Immun

  2026-07-12

  Explore how Promethazine HCl empowers advanced immune and inflammation research as a histaminergic signaling pathway inhibitor. This article delivers a uniquely practical, assay-focused perspective on leveraging promethazine hydrochloride for host-directed antibacterial strategies.

• ACE2 Activation via Diminazene Aceturate Protects Against SI

  2026-07-10

  The referenced study establishes that activation of ACE2 using Diminazene Aceturate mitigates sepsis-induced cardiomyopathy (SIC) in mice by promoting MasR-Sirt1-mediated mitochondrial biogenesis. These findings clarify the cardioprotective mechanism of ACE2 signaling and suggest new research avenues for targeting mitochondrial dysfunction in sepsis.

• Ricin-Induced Necroptosis and Bystander Death in Lung Epithe

  2026-07-09

  Kempen et al. uncover a necroptosis-driven bystander effect in lung epithelial cells following ricin toxin exposure, highlighting the roles of inflammatory cytokines and HMGB1. This work advances understanding of non-apoptotic cell death in toxin-mediated lung injury and informs the refinement of apoptosis assays in respiratory research.

• FAISL lncRNA Blocks FAK Proteolysis to Drive TNBC Progressio

  2026-07-09

  This study elucidates a novel regulatory mechanism in triple negative breast cancer (TNBC), demonstrating that the long noncoding RNA FAISL directly inhibits Calpain 2-mediated proteolysis of FAK, thereby stabilizing FAK protein and promoting tumor progression. These findings provide mechanistic insight into TNBC metastasis and suggest that targeting FAISL could offer new therapeutic opportunities.

• Promethazine HCl (SKU B4784): Reliable Solutions for Immunol

  2026-07-08

  This article provides an evidence-based exploration of Promethazine HCl (SKU B4784) for cell viability, proliferation, and immunology workflows. Drawing on recent literature and scenario-driven laboratory challenges, we demonstrate how Promethazine HCl enables reproducibility, high solubility, and advanced mechanistic studies, particularly for macrophage antibacterial assays and histaminergic signaling investigations.

451 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page